Clinical trial of CDP-choline for the patients with corticobasal degeneration

Clinical trial of CDP-choline for the patients with corticobasal degeneration - CDP-choline treatment for CBD patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003149

Enrollment

Registered

2010-02-08

Start date

2008-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coticobasal degeneration

Interventions

Factor A(-), Factor A (-)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients meet the clinical criteria of corticobasal degeneration by Japan Intractable Disease Information Center

Exclusion criteria

Exclusion criteria: The patients who showed allergy by previous CDP-choline injection.

Design outcomes

Primary

Measure	Time frame
Neurological Examinations (clumsieness of upper limbs, and gait disturbances) Unified Parkinson's Rating Scale (UPDRS) FIM, MMSE	—

Secondary

Measure	Time frame
FDG-PET findings	—

Countries

Japan

Contacts

Public ContactTadanori Hamano

University of Fukui Second Department of Internal Medicine

hamano@u-fukui.ac.jp0776-61-3111(2300)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026